Income Tax Expense (Benefit) of Tengjun Biotechnology Corp. from 31 Mar 2022 to 30 Jun 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Tengjun Biotechnology Corp. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2022 to 30 Jun 2023.
Tengjun Biotechnology Corp. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2023 was $2,264, a 100% decline year-over-year.
Tengjun Biotechnology Corp. Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2023 was $2,903,292.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Tengjun Biotechnology Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	$2,903,292	$2,264	-$505,495	-100%	01 Apr 2023	30 Jun 2023	10-Q	15 Aug 2023	2023	Q2
Q1 2023	$3,408,787	$191,811	+$98,856	+106%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$3,309,931	$1,448,101			01 Oct 2022	31 Dec 2022	10-K	17 Apr 2023	2022	FY
Q3 2022		$1,265,644			01 Jul 2022	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022		$503,231			01 Apr 2022	30 Jun 2022	10-Q	15 Aug 2023	2023	Q2
Q1 2022		$92,955			01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2022	$3,309,931			01 Jan 2022	31 Dec 2022	10-K	17 Apr 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.